YongliJiMD

PubMed

• 3 citations
  Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations.
  Andreas Varkaris, Ferran Fece de la Cruz, Elizabeth E Martin, Bryanna L Norden, Nicholas Chevalier, Allison M Kehlmann, Ignaty Leshchiner, Haley Barnes, Sara Ehnstrom,...> ;Cancer Discovery. 2024 Feb 8
• 3 citations
  Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia.
  Andreas Varkaris, Ermira Pazolli, Hakan Gunaydin, Qi Wang, Levi Pierce, Alessandro A Boezio, Artemisa Bulku, Lucian DiPietro, Cary Fridrich, Adam Frost, Fabrizio Giord...> ;Cancer Discovery. 2024 Feb 8
• 7 citations
  Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study
  Masanori Mori, Yongli Ji, Santosh Kumar, Takamaru Ashikaga, Steven Ades> ;International Journal of Clinical Oncology. 2017 Apr 1
• 14 citations
  The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk Women.
  Yongli Ji, Tiffany Rounds, Abigail Crocker, Betsy L Sussman, Russell C. Hovey, Fonda S. Kingsley, Hyman B. Muss, Judy Garber, Marie E. Wood> ;Cancer Prevention Research. 2016 May 1
• 92 citations
  Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.
  Yongli Ji, Cathryn Rankin, Steven M. Grunberg, Andy Sherrod, Jamshid Ahmadi, Jeannette J. Townsend, Lynn G. Feun, Ruth K. Fredericks, Christy A. Russell, Fairooz F. Ka...> ;Journal of Clinical Oncology. 2015 Nov 2
• 16 citations
  Successful Treatment of Non-Small Cell Lung Cancer With Erlotinib Throughout Pregnancy.
  Yongli Ji, Joanna Schwartz, Alan C. Hartford, Jon E. Ramsey, Julie K. Phillips, Claire F. Verschraegen> ;JAMA Oncology. 2015 Sep 1
• 12 citations
  Comparison of false positive rates for screening breast magnetic resonance imaging (MRI) in high risk women performed on stacked versus alternating schedules.
  Edress Othman, Jue Wang, Brian L. Sprague, Tiffany Rounds, Yongli Ji, Sally D. Herschorn, Marie E. Wood> ;Springerplus. 2015 Feb 13
• 5 citations
  A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma
  Claire F. Verschraegen, Sujana Movva, Yongli Ji, Berndt Schmit, Robert H. Quinn, Ben Liem, Monte Shaheen> ;Cancers. 2013 Apr 11
• Join now to see all